The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: trastuzumab     Quarter: 2016Q3

Total Drug/Injury Combinations: 450     Number of Pages: 23

DRUGNAME PT EventCount
Trastuzumab Leukocytosis 2 view events
Trastuzumab Lower respiratory tract infection 2 view events
Trastuzumab Lymphoedema 2 view events
Trastuzumab Malnutrition 2 view events
TRASTUZUMAB Maternal exposure during pregnancy 2 view events
Trastuzumab Melaena 2 view events
Trastuzumab Mucosal infection 2 view events
Trastuzumab Multiple organ dysfunction syndrome 2 view events
Trastuzumab Nail discolouration 2 view events
Trastuzumab Nasal discomfort 2 view events
Trastuzumab Neurotoxicity 2 view events
TRASTUZUMAB Neutropenic colitis 2 view events
Trastuzumab Neutropenic sepsis 2 view events
Trastuzumab Oedema peripheral 2 view events
TRASTUZUMAB Oxygen saturation decreased 2 view events
Trastuzumab Panic attack 2 view events
TRASTUZUMAB Pericardial disease 2 view events
Trastuzumab Peripheral ischaemia 2 view events
Trastuzumab Posterior reversible encephalopathy syndrome 2 view events
TRASTUZUMAB Premature delivery 2 view events

Total Drug/Injury Combinations: 450     Number of Pages: 23

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)